These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2987005

  • 1. DNA topoisomerase I and II activities during cell proliferation and the cell cycle in cultured mouse embryo fibroblast (C3H 10T1/2) cells.
    Tricoli JV, Sahai BM, McCormick PJ, Jarlinski SJ, Bertram JS, Kowalski D.
    Exp Cell Res; 1985 May; 158(1):1-14. PubMed ID: 2987005
    [Abstract] [Full Text] [Related]

  • 2. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.
    Meyer KN, Kjeldsen E, Straub T, Knudsen BR, Hickson ID, Kikuchi A, Kreipe H, Boege F.
    J Cell Biol; 1997 Feb 24; 136(4):775-88. PubMed ID: 9049244
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of proliferation in determining sensitivity to topoisomerase II-active chemotherapy agents.
    Sullivan DM, Chow KC, Glisson BS, Ross WE.
    NCI Monogr; 1987 Feb 24; (4):73-8. PubMed ID: 2819735
    [Abstract] [Full Text] [Related]

  • 5. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K, Petersen BO, Falck J, Helin K, Jensen PB, Sehested M.
    Clin Cancer Res; 2000 Apr 24; 6(4):1488-97. PubMed ID: 10778981
    [Abstract] [Full Text] [Related]

  • 6. Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II.
    Burden DA, Goldsmith LJ, Sullivan DM.
    Biochem J; 1993 Jul 01; 293 ( Pt 1)(Pt 1):297-304. PubMed ID: 8392338
    [Abstract] [Full Text] [Related]

  • 7. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
    Smith PJ, Souès S, Gottlieb T, Falk SJ, Watson JV, Osborne RJ, Bleehen NM.
    Br J Cancer; 1994 Nov 01; 70(5):914-21. PubMed ID: 7947097
    [Abstract] [Full Text] [Related]

  • 8. Topoisomerase-specific drug sensitivity in relation to cell cycle progression.
    Chow KC, Ross WE.
    Mol Cell Biol; 1987 Sep 01; 7(9):3119-23. PubMed ID: 2823120
    [Abstract] [Full Text] [Related]

  • 9. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.
    Sullivan DM, Latham MD, Ross WE.
    Cancer Res; 1987 Aug 01; 47(15):3973-9. PubMed ID: 3038304
    [Abstract] [Full Text] [Related]

  • 10. Effect of camptothecin on mitogenic stimulation of human lymphocytes: involvement of DNA topoisomerase I in cell transition from G0 to G1 phase of the cell cycle and in DNA replication.
    Bruno S, Giaretti W, Darzynkiewicz Z.
    J Cell Physiol; 1992 Jun 01; 151(3):478-86. PubMed ID: 1338332
    [Abstract] [Full Text] [Related]

  • 11. Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy.
    Baker SD, Wadkins RM, Stewart CF, Beck WT, Danks MK.
    Cytometry; 1995 Feb 01; 19(2):134-45. PubMed ID: 7743894
    [Abstract] [Full Text] [Related]

  • 12. Growth state and cell cycle dependent phosphorylation of DNA topoisomerase II in Swiss 3T3 cells.
    Saijo M, Ui M, Enomoto T.
    Biochemistry; 1992 Jan 21; 31(2):359-63. PubMed ID: 1310036
    [Abstract] [Full Text] [Related]

  • 13. Functional interactions of DNA topoisomerases with a human replication origin.
    Abdurashidova G, Radulescu S, Sandoval O, Zahariev S, Danailov MB, Demidovich A, Santamaria L, Biamonti G, Riva S, Falaschi A.
    EMBO J; 2007 Feb 21; 26(4):998-1009. PubMed ID: 17290216
    [Abstract] [Full Text] [Related]

  • 14. Type I topoisomerase activity after infection of enucleated, synchronized mouse L cells by vaccinia virus.
    Poddar SK, Bauer WR.
    J Virol; 1986 Feb 21; 57(2):433-7. PubMed ID: 3003375
    [Abstract] [Full Text] [Related]

  • 15. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
    Lefevre D, Riou JF, Ahomadegbe JC, Zhou DY, Benard J, Riou G.
    Biochem Pharmacol; 1991 Jun 15; 41(12):1967-79. PubMed ID: 1645555
    [Abstract] [Full Text] [Related]

  • 16. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
    Heck MM, Hittelman WN, Earnshaw WC.
    Proc Natl Acad Sci U S A; 1988 Feb 15; 85(4):1086-90. PubMed ID: 2829215
    [Abstract] [Full Text] [Related]

  • 17. Effects of antitumor compounds isolated from Pteris semipinnata L on DNA topoisomerases and cell cycle of HL-60 cells.
    Li JH, He CW, Liang NC, Mo LE, Zhang X.
    Zhongguo Yao Li Xue Bao; 1999 Jun 15; 20(6):541-5. PubMed ID: 10678150
    [Abstract] [Full Text] [Related]

  • 18. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S, Benchokroun Y, Larsen AK.
    Mol Pharmacol; 1995 May 15; 47(5):898-906. PubMed ID: 7746278
    [Abstract] [Full Text] [Related]

  • 19. Topoisomerase II: A specific marker for cell proliferation.
    Heck MM, Earnshaw WC.
    J Cell Biol; 1986 Dec 15; 103(6 Pt 2):2569-81. PubMed ID: 3025219
    [Abstract] [Full Text] [Related]

  • 20. Type II topoisomerase activities in both the G1 and G2/M phases of the dinoflagellate cell cycle.
    Mak CK, Hung VK, Wong JT.
    Chromosoma; 2005 Dec 15; 114(6):420-31. PubMed ID: 16252092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.